Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Charles River Labs Intl buy Jefferies Financial Group Inc.

Start price
€134.00
09.09.25 / 50%
Target price
€165.63
09.09.26
Performance (%)
24.59%
Price
€166.95
17.12.25
Summary
This prediction is currently active. The prediction currently has a performance of 24.59%. This prediction currently runs until 09.09.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Charles River Labs Intl 0.180% 0.180%
iShares Core DAX® -1.212% 1.925%
iShares Nasdaq 100 -4.714% -1.810%
iShares Nikkei 225® -2.976% -2.660%
iShares S&P 500 -2.744% -0.448%

Comments by Jefferies_Financial_ for this prediction

In the thread Charles River Labs Intl diskutieren
Prediction Buy
Perf. (%) 24.59%
Target price 165.633
Change
Ends at 09.09.26

Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $195.00 price target on the stock, up previously from $142.00.
Ratings data for CRL provided by MarketBeat